Adrian Prasetya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adrian Prasetya has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aisyah Amalia
Radiology Resident of Radiology Specialist Study Program, Faculty of Medicine, Universitas Brawijaya/ Dr. Saiful Anwar Hospital, Malang, East Java, Indonesia
1 shared publication - Dwi Yuni Nur Hidayati
Department of Clinical Microbiology, Faculty of Medicine, University of Brawijaya, Malang, Indonesia
1 shared publication - Elsa Larissa Widyani
Master Program in Biomedical Science, Faculty of Medicine, University of Brawijaya, Malang, Indonesia
1 shared publication - Genitri Indraswari
Master Program in Biomedical Science, Faculty of Medicine, University of Brawijaya, Malang, Indonesia
1 shared publication - Merika Soraya
²Undergraduate Medical Program, Faculty of Medicine, Universitas Negeri Surabaya, Surabaya, Indonesia
1 shared publication - Septha Rully
Master Program in Biomedical Science, Faculty of Medicine, University of Brawijaya, Malang, Indonesia
1 shared publication
Latest Publications
- Open Access
- 15 June 2022
- Published by Wiley in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2022, 1-9
Cross Protectivity Analysis of 49.8 kDa Pili Subunits of S. flexneri against Vibrio cholerae Infection
Background. Although the AMV and AMS vaccine candidates have similar characteristics as hemagglutinin and adhesive molecules, there are differences in molecular weight. Objective. The research aims to determine the immunological cross-reaction between AMS and AMV. Method. Antihemagglutination test used the anti-adhesion molecular antibody AMS. Next, we examined the immune response that has to be linked with protectivity. The model of the research uses MLIL. The sample separated the mice into four groups, and each group had five mice. The first group was the negative control group. The second group was given AMV and infected with Shigella flexneri. The third group was immunized with AMV before being exposed to Shigella flexneri. The last group was infected with Vibrio cholerae. The immune response results were evaluated by calculating the weight of MLIL and counting the colony of bacteria. We also examined other AMS immune responses, namely, β-defensin and s-IgA levels. To get the data, we measured the number of Th17 immune effector cells, T-reg, and proinflammatory cytokine IL-17A. Data analysis was performed using ANOVA, independent t-test, Kruskal–Wallis, and Mann–Whitney tests. Results. An antihemagglutination cross immune response, intestinal weight, the number of bacterial colonies, and other findings were found to be significant ( ) for the levels of β-defensin, s-IgA, Th17, T-reg, and IL-17A. Conclusion. The 49.8 kDa·MW protein subunit of the Shigella flexneri adhesion molecule could act as a candidate vaccine homologous for shigellosis and cholera in the future.
- 15 June 2022
- Published by Wiley in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2022, 1-9
Open AccessCross Protectivity Analysis of 49.8 kDa Pili Subunits of S. flexneri against Vibrio cholerae Infection
Background. Although the AMV and AMS vaccine candidates have similar characteristics as hemagglutinin and adhesive molecules, there are differences in molecular weight. Objective. The research aims to determine the immunological cross-reaction between AMS and AMV. Method. Antihemagglutination test used the anti-adhesion molecular antibody AMS. Next, we examined the immune response that has to be linked with protectivity. The model of the research uses MLIL. The sample separated the mice into four groups, and each group had five mice. The first group was the negative control group. The second group was given AMV and infected with Shigella flexneri. The third group was immunized with AMV before being exposed to Shigella flexneri. The last group was infected with Vibrio cholerae. The immune response results were evaluated by calculating the weight of MLIL and counting the colony of bacteria. We also examined other AMS immune responses, namely, β-defensin and s-IgA levels. To get the data, we measured the number of Th17 immune effector cells, T-reg, and proinflammatory cytokine IL-17A. Data analysis was performed using ANOVA, independent t-test, Kruskal–Wallis, and Mann–Whitney tests. Results. An antihemagglutination cross immune response, intestinal weight, the number of bacterial colonies, and other findings were found to be significant ( ) for the levels of β-defensin, s-IgA, Th17, T-reg, and IL-17A. Conclusion. The 49.8 kDa·MW protein subunit of the Shigella flexneri adhesion molecule could act as a candidate vaccine homologous for shigellosis and cholera in the future.